Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AAM Steps Into GSK-Teva Case To Defend Carve-Outs
Ruling On Skinny Labels Must Not Become ‘Road Map’ For Originators
Dec 17 2020
•
By
David Wallace
Generics firms must be able to carve out indications, the AAM says • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin